Ketosis Prone Diabetes

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Ketosis Prone Diabetes trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT07167693

Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes

Diabetic ketoacidosis (DKA) is increasingly recognized in adults with "ketone-prone" type 2 diabetes. In many of these patients, the pancreas can still make ins…

United States60 participantsStarted 2025-12-19

Treatment: Arginine hydrochloride, Sodium Chloride 0.9%

All recent trials (6 shown)

Active — Not RecruitingPhase 4

NCT06699810

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

The goal of this study is to quantify day-to-day changes in blood glucose during treatment towards remission in ketosis-prone diabetes (KPDM) and describe them…

United States12 participantsStarted 2025-01-23

Treatment: Continuous Glucose Monitoring, Insulin

CompletedNot Applicable

NCT05168657

Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth

This is a study assessing the feasibility of using the insulin-only configuration of the iLet bionic pancreas with initiation in pump-naïve people with type 1 d…

United States54 participantsStarted 2022-03-31

Treatment: Bionic Pancreas, Usual Care

Ketosis Prone Diabetes

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes

All recent trials (6 shown)

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes

All recent trials (6 shown)

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth

Study of Arginine and Nitric Oxide in Patients With Diabetes

Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment

Ketosis Prone Diabetes in African-Americans